Stintzing, S; Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, RD; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Ohler, L; Gruenberger, B; Niedersuess-Beke, D; Winder, T; Trojan, J; Prager, GW; Baraniskin, A; Klein-Scory, S.
Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC.
J CLIN ONCOL. 2023; 41(16):
[Poster]
Web of Science